A pharmaceutical company accused of suppressing negative studies of
its antidepressant drugs has agreed to publish all information from
its clinical trials.
GlaxoSmithKline also agreed to pay $2.5m in a settlement with New
York State attorney general Eliot Spitzer. The company had already
agreed to publish information about its drug Seroxat, following
allegations that studies suggesting links with suicidal feelings in
children were suppressed. It will now publish all its drug trial
data since December 2000 on the internet.
GlaxoSmithKline insisted the charges were unfounded but said it had
settled the case to avoid the cost of protracted litigation.